Net Cash Provided by (Used in) Operating Activities |
-710K |
USD |
-144% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
60K |
USD |
|
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
547K |
USD |
+775% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-103K |
USD |
+54.8% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
46.9K |
USD |
-91.2% |
Q2 2023 |
Q2 2023 |
Deferred Tax Assets, Valuation Allowance |
414K |
USD |
+182% |
Q4 2022 |
FY 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2023 |
Q1 2023 |
Cash and Cash Equivalents, Period Increase (Decrease) |
-228K |
USD |
-347% |
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Gross |
414K |
USD |
+175% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
-100% |
Q4 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2023 |
Q1 2023 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2023 |
Q2 2023 |
Additional Paid in Capital |
0 |
USD |
|
Q1 2023 |
Q1 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
365K |
USD |
|
Q4 2022 |
FY 2022 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q1 2023 |
Q1 2023 |
Interest Expense |
1.1K |
USD |
|
Q1 2023 |
Q1 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
Q2 2023 |